Previous 10 | Next 10 |
Quarterhill Appoints John Karnes as CFO Canada NewsWire TORONTO , May 24, 2022 /CNW/ - Quarterhill Inc. ("Quarterhill" or "the Company") (TSX: QTRH) (OTCQX: QTRHF) announces that John Karnes has been appointed Chief Financial Officer ("CFO") of the Co...
If there’s one strategy growing in popularity right now, it’s “follow” the money. Whether you’re looking for penny stocks to buy or which stocks to invest in, “smart money” is a focus for many. Most companies won’t come out to state wh...
SUNNYVALE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company, announced today that it will report financial results for the fiscal year 2022 (FY2022) fourth quarter and full year after the ma...
In this podcast, Motley Fool contributor Brian Orelli interviews Anne Wojcicki, the CEO of 23andMe (NASDAQ: ME) , about her company and why it's looking to tell you much more than the names of your long-lost relatives. They discuss: To catch full episodes of all The Motley F...
Citi Investment Research has grouped telehealth provider, Teladoc Health (NYSE:TDOC) and membership-based primary care platform 1Life Healthcare (ONEM) among health tech stocks highly exposed to the risk of a recession. This month, the economists polled by The Wall Street Journal...
The stock performance of 23andMe (NASDAQ: ME) has plunged since it went public last June. But, in this video clip from "The Rank" on Motley Fool Live , recorded on March 28 , Fool.com contributors Matt Frankel and Travis Hoium discuss a few of the biotech company's promising...
SUNNYVALE, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and therapeutics company with a mission to help people access, understand, and benefit from the human genome, today announced that it will present da...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips SPACs (special purpose acquisition companies) and meme stocks made numerous headlines in 2021 and continue to spark interest in investors in 2022. People have plenty of questions about SPACs: Are they a good investment? Wha...
SUNNYVALE, Calif., Feb. 25, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and research company with a mission to help people access, understand, and benefit from the human genome, announced today that management will be pres...
23andMe Holding Co. is gearing up to capitalize on its growing genetic database by investing in new business verticals and industry-first services. The company engages in dialogue with the FDA and watch groups to ensure that its personalized services do not violate current or future g...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report financial resu...
SUNNYVALE, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading genetic health and biopharmaceutical company, in collaboration with 20 lung cancer advocacy organizations, today announced a new study to help advance research in lung cancer. The focus of the Lun...